Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
Perhaps it's the sweet California air, but the pervasive (though not universal) pessimism in biopharma these days is really bumming me out. Consequently, I'd like to discuss three potential responses to difficult industry problems.
The question of what enables some militaries to innovate effectively is of great interest to both scholars and commanders. However, the traditional models of military innovation fail to capture the complex innovation process.
A century from now, observers may well identify the last months of 2011 as the start of higher education’s Great Disruption.
It’s easy to muster a cynical response to Tuesday’s announcement that the world’s largest health products company, J&J, is replacing their current CEO William Weldon (athletic white male and former sales rep who rose through the commercial organization) with Alex Gorsky (athletic ...
In this age of ballooning U.S. debt, it’s hardly surprising that many Democrats and Republicans are pushing to reduce American military spending. But a closer examination of what’s at stake reveals just how troubling the embrace of defense austerity will prove to be.





